Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SemiBull who wrote (877)	1/9/2002 8:20:43 PM
From: SemiBull	Read Replies (1) of 3044

Millennium Pharmaceuticals Announces Webcast of Presentation at the Wachovia Securities Integrated Oncology Conference CAMBRIDGE, Mass., Jan. 9 /PRNewswire/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM - news) announced today that its presentation to the Wachovia Securities Integrated Oncology Conference will be webcast live and may be accessed at under the 'investor relations' tab at www.millennium.com. (Photo: newscom.com ) Millennium senior management will provide an overview of the Millennium oncology franchise program. The presentation will be delivered at 10:30am Eastern Time on January 16, 2002, from the St. Regis Hotel in New York City. Millennium, a leading biopharmaceutical company, applies its comprehensive and integrated science and technology platform for the discovery and development of breakthrough therapeutic and predictive medicine products, with a goal of delivering personalized medicine. Through the industrialization of this gene-to-patient platform, Millennium is also striving to accelerate the process of drug discovery and development. Headquartered in Cambridge, Massachusetts, Millennium currently employs more than 1,500 people. Editor's Note: This release is available on Millennium's website at www.millennium.com Contact: Cynthia Clayton (investor relations) (617) 551-8607 Millennium Pharmaceuticals, Inc. SOURCE: Millennium Pharmaceuticals, Inc.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next